![](/img/cover-not-exists.png)
68 An audit of the use of first-line EGFR TKI treatment in NSCLC patients with EGFR activating mutations at the York Teaching Hospitals and Harrogate and District NHS Foundation Trust
Bhagawati-Prasad, V., Aspden, E., Chan, S., Darby, A.Volume:
91
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(16)30085-x
Date:
January, 2016
File:
PDF, 71 KB
english, 2016